Professor Russell Ware

Dr. Ware is an internationally recognized expert in pediatric hematology with special interest in sickle cell disease. He trained at Duke University, receiving both MD and PhD degrees there. He joined Cincinnati Children’s Hospital in 2013 and directs the Division of Hematology and the Global Health Center. His NIH-funded laboratory studies hydroxyurea therapy and genetic modifiers of sickle cell disease. His NIH-funded national trials related to hydroxyurea include HUG-KIDS, BABY HUG, HUSTLE, SWiTCH, and TWiTCH. His international clinical trials include EXTEND, SACRED, REACH, NOHARM, and PIVOT, and he currently has research partnerships in the Caribbean and across sub-Saharan Africa. He has also conducted sickle surveillance studies in Angola, Uganda, Tanzania, and Malawi. Dr. Ware has published over 400 scientific papers and chapters and was an expert panel member for the NHLBI Evidence-Based Guidelines for Sickle Cell Disease.